Cargando…

The Influence of Invariant Natural Killer T Cells on Humoral Immunity to T-Dependent and -Independent Antigens

Vaccination with CD1d-binding glycolipid adjuvants and co-administered protein, lipid, and carbohydrate antigens leads to invariant natural killer T (NKT) cell-dependent enhancement of protective B cell responses. NKT cell activation boosts the establishment of protein antigen-specific B cell memory...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lang, Mark L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827355/ https://www.ncbi.nlm.nih.gov/pubmed/29520280 http://dx.doi.org/10.3389/fimmu.2018.00305

Ejemplares similares

Immunometabolic Activation of Invariant Natural Killer T Cells
por: Ververs, Francesca A., et al.
Publicado: (2018)

Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients
por: Lezmi, Guillaume, et al.
Publicado: (2018)

The Yin and Yang of Invariant Natural Killer T Cells in Tumor Immunity—Suppression of Tumor Immunity in the Intestine
por: Wang, Ying, et al.
Publicado: (2018)

Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity
por: Van Kaer, Luc, et al.
Publicado: (2018)

Activation of Invariant Natural Killer T Cells Redirects the Inflammatory Response in Neonatal Sepsis
por: Bolognese, Alexandra C., et al.
Publicado: (2018)

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
por: Lam, Pui Yeng, et al.
Publicado: (2017)

Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells
por: Garner, Lucy C., et al.
Publicado: (2018)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
por: Popovic, Zoran V., et al.
Publicado: (2017)

Harnessing invariant natural killer T cells to control pathological inflammation
por: Bharadwaj, Nikhila S., et al.
Publicado: (2022)

Antigen specificity of invariant natural killer T-cells
por: Birkholz, Alysia M., et al.
Publicado: (2015)

Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells
por: Doherty, Derek G., et al.
Publicado: (2018)

Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections
por: Trottein, François, et al.
Publicado: (2018)

Impact of Aging on the Phenotype of Invariant Natural Killer T Cells in Mouse Thymus
por: Papadogianni, Georgia, et al.
Publicado: (2020)

Critical Role for Very-Long Chain Sphingolipids in Invariant Natural Killer T Cell Development and Homeostasis
por: Saroha, Ashish, et al.
Publicado: (2017)

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
por: Bernard, Nicole F., et al.
Publicado: (2022)

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells
por: Paquin-Proulx, Dominic, et al.
Publicado: (2018)

Invariant Natural Killer T Cell Subsets—More Than Just Developmental Intermediates
por: Krovi, S. Harsha, et al.
Publicado: (2018)

Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis
por: Kumar, Vipin, et al.
Publicado: (2023)

Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy
por: Shissler, Susannah C., et al.
Publicado: (2017)

A humanized mouse model for in vivo evaluation of invariant Natural Killer T cell responses
por: Saavedra-Avila, Noemi Alejandra, et al.
Publicado: (2022)

Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control
por: Kinjo, Yuki, et al.
Publicado: (2018)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018)

T Cell Receptor Expression Timing and Signal Strength in the Functional Differentiation of Invariant Natural Killer T Cells
por: Dashtsoodol, Nyambayar, et al.
Publicado: (2019)

Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis
por: Xue, Rufeng, et al.
Publicado: (2018)

Invariant Natural Killer T Cells Ameliorate Monosodium Urate Crystal-Induced Gouty Inflammation in Mice
por: Wang, Jie, et al.
Publicado: (2017)

Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections
por: Schäfer, Alexander, et al.
Publicado: (2019)

Serpinb1a Is Dispensable for the Development and Cytokine Response of Invariant Natural Killer T Cell Subsets
por: Leborgne, Nathan G. F., et al.
Publicado: (2020)

Mucosa associated invariant T and natural killer cells in active and budesonide treated collagenous colitis patients
por: Daferera, Niki, et al.
Publicado: (2022)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

New Genetically Manipulated Mice Provide Insights Into the Development and Physiological Functions of Invariant Natural Killer T Cells
por: Ren, Yue, et al.
Publicado: (2018)

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
por: Hermanson, David L., et al.
Publicado: (2015)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
por: Mavers, Melissa, et al.
Publicado: (2017)

The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell Generation
por: Gottschalk, Catherine, et al.
Publicado: (2015)

Invariant Natural Killer T Cells Shape the Gut Microbiota and Regulate Neutrophil Recruitment and Function During Intestinal Inflammation
por: Shen, Sj, et al.
Publicado: (2018)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Differentiation of IL-17-Producing Invariant Natural Killer T Cells Requires Expression of the Transcription Factor c-Maf
por: Yu, Jhang-Sian, et al.
Publicado: (2017)

Distinct Bioenergetic Features of Human Invariant Natural Killer T Cells Enable Retained Functions in Nutrient-Deprived States
por: Khurana, Priya, et al.
Publicado: (2021)

Temporal Regulation of Natural Killer T Cell Interferon Gamma Responses by β-Catenin-Dependent and -Independent Wnt Signaling
por: Kling, Jessica C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_addf0m4ta9lsfjugg6t6adba67